Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes (Q43252247)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 October 2009
edit
Language Label Description Also known as
English
Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes
scientific article published on 29 October 2009

    Statements

    Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes (English)
    William H Herman
    Rury R Holman
    Barbara G Kravitz
    Gitanjali Paul
    R Paul Aftring
    Giancarlo Viberti
    ADOPT Study Group
    29 October 2009
    134-142

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit